Carlsmed, Inc. (CARL)

Carlsmed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	33.47	40.13	7.22
Cash & Short-Term Investments	33.47	40.13	7.22
Cash Growth	-	455.59%	-
Receivables	9.71	6.77	3.17
Inventory	1.07	1	0.58
Prepaid Expenses	1.84	1.37	0.65
Restricted Cash	0.1	0.1	0.15
Total Current Assets	46.19	49.35	11.77
Property, Plant & Equipment	3.12	1.9	2.24
Long-Term Deferred Charges	3.8	0.4	-
Other Long-Term Assets	0.16	0.17	0.02
Total Assets	53.27	51.82	14.02
Accounts Payable	2.58	2.41	1.69
Accrued Expenses	6.33	5.96	3.6
Current Portion of Long-Term Debt	-	-	1.84
Current Portion of Leases	0.57	0.45	0.31
Total Current Liabilities	9.48	8.82	7.44
Long-Term Debt	15.43	15.41	7.47
Long-Term Leases	1.71	1.32	1.77
Other Long-Term Liabilities	0.99	0.68	0.1
Total Liabilities	27.61	26.23	16.78
Additional Paid-In Capital	0.59	0.54	0.78
Retained Earnings	-83.67	-71.17	-46.91
Total Common Equity	-83.07	-70.63	-46.13
Shareholders' Equity	25.66	25.6	-2.75
Total Liabilities & Equity	53.27	51.82	14.02
Total Debt	17.71	17.18	11.39
Net Cash (Debt)	15.77	22.95	-4.17
Net Cash Per Share	3.69	5.64	-1.07
Filing Date Shares Outstanding	26.58	4.23	3.89
Total Common Shares Outstanding	4.6	4.23	3.89
Working Capital	36.71	40.53	4.33
Book Value Per Share	-18.04	-16.68	-11.87
Tangible Book Value	-83.07	-70.63	-46.13
Tangible Book Value Per Share	-18.04	-16.68	-11.87
Machinery	0.72	0.58	0.4
Leasehold Improvements	0.24	0.08	0.08

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q